Russell Investments Group’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-76	Closed	-$157	–	3774
2024 Q3	$157	Sell	76 -1,405	-95%	-$2.9K	﹤0.01%	3656
2024 Q2	$5.64K	Buy	+1,481	New	+$5.64K	﹤0.01%	3188